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Volume 57, Number 5S Abstracts 101S62.7%, and 61.6% of patients, respectively. Internal jugular
vein stenosis was not present in 18.1% of patients, present
unilaterally in 33.3% of patients, and present bilaterally in
48.5% of patients. Subclavian vein stenosis was not present
in 24.1% of patients, present unilaterally in 32.5% of
patients, and present bilaterally in 43.5% of patients. Signif-
icant collaterals were present in 26.80% of high stenosis,
21.5% of medium and 12.8% of low.
Conclusions: Internal jugular vein stenosis is common
in patients with thoracic outlet symptoms. Treatment of
internal jugular vein stenosis potentially could beneﬁt these
patients. These ﬁndings could fundamentally change the
diagnosis and treatment of thoracic outlet syndrome.Fur-
ther studies are warranted.
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Objectives: Failure after surgical treatment for neuro-
genic thoracic outlet syndrome (nTOS) is a frustrating
problem for both patients and physicians. Fortunately,
many patients with unresolved or recurrent symptoms
demonstrate a mechanical etiology at operation owing to
inadequate previous rib resection, rib regrowth, or scar
tissue formation. The purpose of this study is to evaluate
the utility of multidetector computed tomography (CT)
in predicting surgical outcomes in patients with recurrent
nTOS.
Methods: A retrospective chart-review was performed
of a TOS referral practice from 2003-2012. In 2003,
a dedicated TOS CT protocol was established to assist in
clinical decision making and operative planning. Imaging
as well as patient clinical characteristics, interventions,
and outcomes were reviewed.
Results: 218 TOS operations were performed on 139
patients. These included 20 reoperations for neurogenic
symptoms. Mean time to failure of primary surgery was
26.6 months, mean follow-up after reoperation was 43.3
months. 60% of redo cases were in females, mean age was
34.8 years. Sixteen procedures involved transaxillary rib
resections with brachial plexus neurolysis (80%). Only 5
(25%) cases involved inadequate previous rib resections;
the remainder for scar tissue (50%) and/or rib regrowth
(40%). There were no neurovascular injuries or complica-
tions other then pneumothorax associated with planned
pleurectomy in ten cases (50%). Nine patients (45%)
demonstrated signiﬁcant improvement or resolution of
symptoms, seven patients (35%) received moderate
improvement in symptoms, and four patients (20%) showed
minimal improvement. Positive-predictive value for the use
of CT in predicting a good surgical outcome was 92.3%.Conclusions: Recurrent thoracic outlet syndrome is
an often vexing problem with challenging solutions. These
results demonstrate the utility of a TOS protocol CT scan
for patient selection and operative planning.
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Objectives: Plasma 25 hydroxycholecaliferol (vit D)
has been associated with adverse cardiovascular outcomes
in epidemiological studies. CKD is associated with loss of
1-a-hydroxylase and vitDdeﬁciency (vitDdef).We hypoth-
esized that vit D def is associated with increased mortality
and decreased vascular access patency in patients undergoing
permanent vascular access for end stage renal disease.
Methods: Case series of 129 patients undergoing
permanent vascular access surgery who also had concurrent
plasma vit D levels. Vit D levels were considered deﬁcient
at <20 ng/mL, insufﬁcient at 21-29, and normal >30
ng/mL. Mortality and vascular access patency were evalu-
ated using multivariate logistic regression models.
Results: The mean age was 66.6, 96.1% were male
and 31.8% African American. 61.2% had diabetes mellitus.
In the entire cohort 75.2% were either insufﬁcient or deﬁ-
cient. Mean follow up time was 2.96 years during which
there were 41 (31.8%) deaths and 79 (64.75%) vascular
access events. Vit D deﬁcient patients tended to be younger
(P ¼ .007), have higher total cholesterol (P ¼ .0002), and
lower calcium levels (P ¼ .031). Despite their younger age,
mortality was signiﬁcantly higher in this group (P ¼ .008)
and AVF patency was worse (P ¼ .015). Age, vit D def,
CAD, HTN, albumin and HgbA1C were associated with
mortality. In multivariate analysis vit D def (OR, 4.26;
CI, 1.37-13.28; P ¼ .012), CAD (OR, 3.56; CI, 1.24-
10.24; P ¼ .018), age (OR, 1.08; CI, 1.03-1.15; P ¼
.002), and albumin (OR, .23; CI, 0.07-0.74; P ¼ .014)
remained signiﬁcant. Vit D deﬁciency (P ¼ .036) and
low hematocrit (P ¼ .011) were independently associated
with a loss of AVF patency.
Conclusions: Vit D deﬁciency is highly prevalent in
patients undergoing vascular access procedures. Patients
who are deﬁcient haveworse survival andmore access related
events. Further study is warranted to assess whether vitamin
D repletion will improve outcomes in this population.
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